← OMEGA HEALTHCARE INVESTORS INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income From Continuing Operations | — | — | — | — | — | — | $438.8m | $248.8m | $417.8m | $609.5m | |
| Net Income (Loss) Attributable to Parent | $383.4m | $104.9m | $293.9m | $351.9m | $163.5m | $428.3m | $438.8m | $248.8m | $417.8m | $590.2m | |
| Net Income (Loss) Available to Common Stockholders, Basic | $366.4m | $100.4m | $281.6m | $341.1m | $159.3m | $416.7m | $426.9m | $242.2m | $406.3m | $572.0m | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | — | — | $293.9m | $351.9m | $163.5m | $428.3m | $438.8m | $248.8m | $417.8m | $609.5m | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $17.0m | $4.5m | $12.3m | $10.8m | $4.2m | $11.6m | $11.9m | $6.6m | $11.5m | $19.3m | |
| Depreciation, Depletion and Amortization | $267.1m | $287.6m | $281.3m | $301.7m | $329.9m | $342.0m | $332.4m | $319.7m | $304.6m | $325.2m | |
| Amortization of Debt Issuance Costs | $9.3m | $9.5m | $9.0m | $9.6m | $10.1m | $12.3m | $12.9m | $13.7m | $10.4m | $6.0m | |
| Amortization of Intangible Assets | $13.9m | $11.9m | — | — | — | — | — | — | — | — | |
| Amortization of deferred financing costs and loss on debt extinguishment | $11.5m | $19.7m | $9.0m | $9.6m | $11.6m | $43.1m | $13.3m | $14.2m | $12.1m | $968k | |
| Depreciation Amortization Depletion | — | — | — | — | — | — | $332.4m | $319.7m | $304.6m | $325.2m | |
| Share-based Payment Arrangement, Noncash Expense | $13.8m | $15.2m | $16.0m | $15.4m | $18.8m | $21.4m | $27.3m | $35.1m | $36.7m | $44.2m | |
| Share-based Payment Arrangement, Expense | — | — | — | — | — | $21.4m | $27.3m | $35.1m | $36.7m | $44.2m | |
| Equity Method Investment, Other than Temporary Impairment | — | — | $0 | $0 | $0 | $0 | $0 | — | — | — | |
| Goodwill, Impairment Loss | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Impairment on real estate properties | $58.7m | $99.1m | $35.0m | $48.9m | $76.0m | $44.7m | $38.5m | $91.9m | $23.8m | $22.6m | |
| Asset Impairment Charge | — | — | — | — | — | — | $38.5m | $91.9m | $23.8m | $22.6m | |
| Income (Loss) from Equity Method Investments | $439k | $2.2m | $381k | $10.9m | $6.1m | $16.1m | $7.3m | ($582k) | $7.9m | ($218k) | |
| Gain (Loss) on Extinguishment of Debt | — | — | — | — | ($13.3m) | ($30.8m) | ($389k) | ($492k) | ($1.7m) | $5.0m | |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | — | $53.9m | $24.8m | — | — | — | — | — | — | — | |
| Gain (Loss) on Disposition of Assets | $50.2m | $53.9m | $24.8m | $55.7m | $19.1m | $161.6m | $360.0m | $79.7m | $13.2m | $67.3m | |
| Income Tax Expense (Benefit) | $1.4m | $3.2m | $3.0m | $2.8m | $4.9m | $3.8m | $4.6m | $6.3m | $10.9m | $14.7m | |
| Operating Lease, Lease Income | — | — | $0 | $804.1m | $753.4m | $923.7m | $750.2m | $825.4m | — | — | |
| Other Nonoperating Income (Expense) | — | — | — | ($207.9m) | $4.9m | $130.3m | $357.6m | $99.5m | $18.2m | $122.4m | |
| Earnings (Loss)es From Equity Investments | — | — | — | — | — | — | $455k | $182k | $1.9m | $6.1m | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| Increase (Decrease) in Accounts Receivable | $4.9m | — | — | — | — | — | — | — | — | — | |
| Foreign Currency Transaction Gain (Loss), Realized | ($232k) | $311k | $32k | ($42k) | — | — | — | — | — | — | |
| Gain (Loss) on Sale of Properties | — | — | $11.5m | — | — | — | — | — | — | — | |
| General and Administrative Expense | $45.9m | $47.7m | $63.5m | $57.9m | $59.9m | $64.6m | $69.4m | $81.5m | $88.0m | $104.1m | |
| Goodwill | $643.5m | $644.7m | $644.0m | $644.4m | $651.7m | $651.4m | $643.2m | $643.9m | $643.7m | $644.6m | |
| Investment Income, Interest | $173k | $267k | — | — | — | — | — | — | — | — | |
| Nonoperating Income (Expense) | ($175.6m) | ($209.3m) | ($201.1m) | — | — | — | — | — | — | — | |
| Operating Expenses | $391.1m | $647.1m | $408.9m | $432.8m | $734.9m | $777.0m | $799.7m | $793.6m | $648.9m | $688.0m | |
| Financing Receivable, Credit Loss, Expense (Reversal) | — | — | — | — | $34.2m | $76.7m | — | — | — | — | |
| Real Estate Tax Expense | — | — | — | $14.9m | $12.3m | $12.3m | $15.5m | $15.0m | $14.6m | $14.4m | |
| Straight-line rent and other write-offs | — | — | — | — | — | — | — | $20.6m | $4.2m | $28.0m | |
| Provision (recovery) for credit losses | — | — | $6.7m | — | $38.0m | $77.7m | $68.7m | $44.6m | ($15.5m) | $2.3m | |
| Stock-based compensation expense | $13.8m | $15.2m | $16.0m | $15.4m | $18.8m | $21.4m | $27.3m | $35.1m | $36.7m | $44.2m | |
| Gain on assets sold - net | ($50.2m) | ($53.9m) | ($24.8m) | ($55.7m) | ($19.1m) | ($161.6m) | ($360.0m) | ($79.7m) | ($13.2m) | ($67.3m) | |
| Straight-line rent and effective interest receivables | — | — | — | — | — | ($50.7m) | ($59.0m) | ($41.8m) | ($43.0m) | ($50.3m) | |
| Loss from unconsolidated entities | — | — | — | $22k | ($1.3m) | ($2.1m) | $455k | $182k | $1.9m | $6.1m | |
| Other non-cash items | — | — | — | — | — | — | ($51.2m) | ($9.3m) | ($1.5m) | ($26.3m) | |
| Contractual receivables | ($4.9m) | ($36.6m) | $2.4m | ($5.9m) | $5.7m | ($23.2m) | $3.0m | ($3.7m) | ($845k) | $2.9m | |
| Lease inducements | $2.6m | ($8.4m) | ($32.7m) | ($42.1m) | ($22.4m) | ($13.7m) | $6.0m | ($15.2m) | ($61k) | ($9.0m) | |
| Other operating assets and liabilities | $2.0m | ($17.2m) | ($34.9m) | ($29.3m) | $15.6m | ($4.9m) | $6.5m | $3.8m | $33.8m | $3.2m | |
| Acquisition of real estate | ($959.7m) | ($385.4m) | ($105.1m) | ($377.8m) | ($105.7m) | ($615.9m) | ($230.0m) | ($262.5m) | ($408.6m) | ($683.0m) | |
| Investments in construction in progress | ($69.0m) | ($86.7m) | ($139.4m) | ($139.7m) | ($75.1m) | ($95.1m) | ($17.1m) | ($44.5m) | ($69.0m) | ($33.6m) | |
| Investment in loan receivables and other | — | — | — | — | ($230.4m) | ($251.5m) | ($372.0m) | ($420.6m) | ($470.0m) | ($173.6m) | |
| Collection of loan principal | — | — | — | — | $159.7m | $156.3m | $345.7m | $165.2m | $207.6m | $246.6m | |
| Investments in unconsolidated entities | ($50.0m) | — | — | ($104.0m) | ($2.5m) | ($10.5m) | ($113k) | ($12.3m) | ($971k) | ($122.1m) | |
| Distributions from unconsolidated entities in excess of earnings | $1.3m | $12.2m | $5.5m | $9.1m | $6.3m | $17.9m | $3.3m | $8.8m | $1.0m | $12.9m | |
| Capital improvements to real estate investments | ($40.5m) | ($37.8m) | ($29.8m) | ($52.9m) | ($31.1m) | ($44.9m) | ($47.2m) | ($38.0m) | ($37.8m) | ($80.9m) | |
| Proceeds from foreign currency forward contracts | — | — | — | — | — | — | — | $11.4m | $8.4m | $4.2m | |
| Receipts from insurance proceeds | — | $2.8m | $8.7m | $8.2m | $897k | $6.0m | $1.3m | $6.8m | $3.1m | $6.8m | |
| Proceeds from long-term borrowings | $1.0b | $1.3b | — | $495.0m | $687.7m | $2.3b | $597.4m | $507.1m | $657.8m | $1.3b | |
| Payments of long-term borrowings | ($181.2m) | ($1.3b) | ($2.0m) | ($101.2m) | ($645.2m) | ($2.2b) | ($589.3m) | ($735.0m) | ($1.1b) | ($1.9b) | |
| Payments of financing related costs | ($11.8m) | ($29.2m) | ($8k) | ($4.8m) | ($18.2m) | ($49.0m) | ($389k) | ($3.8m) | ($7.0m) | ($27.3m) | |
| (Payments for) proceeds from derivative instruments | — | — | — | — | — | — | — | $92.6m | — | ($2.2m) | |
| Redemption of Omega OP Units | ($733k) | ($48k) | ($134k) | — | — | ($79k) | ($9.7m) | ($77k) | ($684k) | ($6.2m) | |
| Distributions to Omega OP Unit Holders | ($21.2m) | ($22.6m) | ($23.5m) | ($21.3m) | ($21.0m) | ($25.2m) | ($20.5m) | ($26.4m) | ($29.3m) | ($43.9m) | |
| Beginning Cash Position | — | — | — | — | — | — | $24.4m | $300.6m | $444.7m | $548.7m | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | — | — | ($789.4m) | ($473.3m) | $26.3m | ($838.3m) | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | — | — | $442.9m | ($770k) | ($671.2m) | ($539.8m) | |
| Change In Other Current Assets | — | — | — | — | — | — | $6.0m | ($15.2m) | ($61k) | ($9.0m) | |
| Change In Other Working Capital | — | — | — | — | — | — | $6.5m | $3.8m | $33.8m | $3.2m | |
| Change In Receivables | — | — | — | — | — | — | $3.0m | ($3.7m) | ($845k) | $2.9m | |
| Change In Working Capital | — | — | — | — | — | — | $15.5m | ($15.1m) | $32.9m | ($2.9m) | |
| Changes In Account Receivables | — | — | — | — | — | — | $3.0m | ($3.7m) | ($845k) | $2.9m | |
| Changes In Cash | — | — | — | — | — | — | $279.1m | $143.7m | $104.6m | ($499.5m) | |
| End Cash Position | — | — | — | — | — | — | $300.6m | $444.7m | $548.7m | $54.6m | |
| Financing Cash Flow | — | — | — | — | — | — | ($789.4m) | ($473.3m) | $26.3m | ($838.3m) | |
| Free Cash Flow | — | — | — | — | — | — | $625.7m | $617.7m | $749.4m | $878.6m | |
| Gain Loss On Investment Securities | — | — | — | — | — | — | ($360.0m) | ($79.7m) | ($13.2m) | ($67.3m) | |
| Investing Cash Flow | — | — | — | — | — | — | $442.9m | ($770k) | ($671.2m) | ($539.8m) | |
| Issuance Of Capital Stock | — | — | — | — | — | — | $8.1m | $336.4m | $1.2b | $609.1m | |
| Net Business Purchase And Sale | — | — | — | — | — | — | ($113k) | ($12.3m) | ($971k) | ($122.1m) | |
| Net PPE Purchase And Sale | — | — | — | — | — | $717k | $0 | $0 | — | — | |
| Operating Gains Losses | — | — | — | — | — | — | ($359.5m) | ($79.5m) | ($11.2m) | ($61.2m) | |
| Provisionand Write Offof Assets | — | — | — | — | — | — | $193.4m | $65.2m | ($11.3m) | $30.3m | |
| Purchase Of Business | — | — | — | — | — | — | ($113k) | ($12.3m) | ($971k) | ($122.1m) | |
| Repurchase Of Capital Stock | — | — | — | — | — | $0 | ($142.3m) | $0 | $0 | — | |
| Sale Of PPE | — | — | — | — | — | $717k | $0 | $0 | — | — | |
| Stock Based Compensation | — | — | — | — | — | — | $27.3m | $35.1m | $36.7m | $44.2m | |
| Net Cash Provided by (Used in) Operating Activities | $625.8m | $577.9m | $499.4m | $553.7m | $708.3m | $722.1m | $625.7m | $617.7m | $749.4m | $878.6m | |
| Cash flows from investing activities: | |||||||||||
| Capital Expenditure | — | — | — | — | — | ($95.1m) | — | — | — | — | |
| Payments to Acquire Businesses, Net of Cash Acquired | — | — | — | $59.6m | $5.1m | — | — | — | — | — | |
| Net Investment Properties Purchase And Sale | — | — | — | — | — | — | $464.7m | $240.1m | ($420.3m) | ($514.7m) | |
| Net Investment Purchase And Sale | — | — | — | — | — | — | $0 | $11.4m | $8.4m | $4.2m | |
| Purchase Of Investment Properties | — | — | — | — | — | — | ($294.3m) | ($345.0m) | ($515.4m) | ($797.5m) | |
| Net proceeds from sale of real estate investments | $169.6m | $257.8m | $309.6m | $219.3m | $180.9m | $318.5m | $759.0m | $585.0m | $95.0m | $282.8m | |
| Sale Of Investment | — | — | — | — | — | — | $0 | $11.4m | $8.4m | $4.2m | |
| Sale Of Investment Properties | — | — | — | — | — | — | $759.0m | $585.0m | $95.0m | $282.8m | |
| Net Other Investing Changes | — | — | — | — | — | — | ($25.1m) | ($248.7m) | ($259.3m) | $79.9m | |
| Net Cash Provided by (Used in) Investing Activities | ($1.1b) | ($285.1m) | ($173.2m) | ($379.0m) | ($89.1m) | ($524.2m) | $442.9m | ($770k) | ($671.2m) | ($539.8m) | |
| Cash flows from financing activities: | |||||||||||
| Issuance Of Debt | — | — | — | — | — | — | $597.4m | $507.1m | $657.8m | $1.3b | |
| Long Term Debt Issuance | — | — | — | — | — | — | $597.4m | $507.1m | $657.8m | $1.3b | |
| Net Issuance Payments Of Debt | — | — | — | — | — | — | $8.1m | ($227.9m) | ($487.5m) | ($585.0m) | |
| Net Long Term Debt Issuance | — | — | — | — | — | — | $8.1m | ($227.9m) | ($487.5m) | ($585.0m) | |
| Long Term Debt Payments | — | — | — | — | — | — | ($589.3m) | ($735.0m) | ($1.1b) | ($1.9b) | |
| Repayment Of Debt | — | — | — | — | — | — | ($589.3m) | ($735.0m) | ($1.1b) | ($1.9b) | |
| Proceeds from Issuance of Common Stock | $19.7m | $22.1m | $75.5m | — | — | — | — | — | — | — | |
| Net proceeds from issuance of common stock | $19.7m | $22.1m | $75.5m | $404.9m | $152.8m | $274.0m | $8.1m | $336.4m | $1.2b | $606.8m | |
| Common Stock Issuance | — | — | — | — | — | — | $8.1m | $336.4m | $1.2b | $609.1m | |
| Net Common Stock Issuance | — | — | — | — | — | — | ($134.2m) | $336.4m | $1.2b | $609.1m | |
| Payments for Repurchase of Common Stock | — | — | — | — | — | — | $142.3m | — | — | — | |
| Common Stock Payments | — | — | — | — | — | $0 | ($142.3m) | $0 | $0 | — | |
| Proceeds from Noncontrolling Interests | — | — | — | $228k | — | — | $81k | — | — | — | |
| Proceeds from (Payments to) Noncontrolling Interests | — | — | — | — | — | — | — | ($202k) | $545k | — | |
| Net payments to noncontrolling members of consolidated joint venture | — | — | — | — | — | — | $81k | ($202k) | $545k | — | |
| Dividends paid | $453 | $503 | $529 | $564 | $612 | $638 | $633 | $644 | $685 | $780 | |
| Cash Dividends Paid | — | — | — | — | — | — | ($632.9m) | ($643.9m) | ($685.4m) | ($780.4m) | |
| Common Stock Dividend Paid | — | — | — | — | — | — | ($632.9m) | ($643.9m) | ($685.4m) | ($780.4m) | |
| Dividends Received CFI | — | — | — | — | — | — | $3.3m | $8.8m | $1.0m | $12.9m | |
| Net Other Financing Charges | — | — | — | — | — | — | ($30.5m) | $62.1m | ($36.4m) | ($82.0m) | |
| Net cash (used in) provided by financing activities | $576.3m | ($303.8m) | ($410.7m) | ($154.0m) | ($485.5m) | ($341.1m) | ($789.4m) | ($473.3m) | $26.3m | ($838.3m) | |
| Net Cash Provided by (Used in) Financing Activities | $576.3m | — | ($410.7m) | ($154.0m) | ($485.5m) | ($341.1m) | ($789.4m) | ($473.3m) | $26.3m | ($838.3m) | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | $568k | ($590k) | $874k | $527k | $7k | ($2.9m) | $430k | ($580k) | $5.3m | |
| Effect Of Exchange Rate Changes | — | — | — | — | — | — | ($2.9m) | $430k | ($580k) | $5.3m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | ($10.5m) | ($85.1m) | $21.7m | $134.2m | ($143.1m) | $276.2m | $144.1m | $104.0m | ($494.2m) | |
| (Decrease) increase in cash, cash equivalents and restricted cash | $87.2m | ($10.5m) | ($85.1m) | $21.7m | $134.2m | ($143.1m) | $276.2m | $144.1m | $104.0m | ($494.2m) | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | $96.8m | $11.7m | $33.4m | $167.6m | $24.4m | $300.6m | $444.7m | $548.7m | $54.6m | |
| Effect of foreign currency translation on cash, cash equivalents and restricted cash | $84k | $568k | ($590k) | $874k | $527k | $7k | ($2.9m) | $430k | ($580k) | $5.3m | |
| Cash, cash equivalents and restricted cash at beginning of period | $107.3m | $96.8m | $11.7m | $33.4m | $167.6m | $24.4m | $300.6m | $444.7m | $548.7m | $54.6m | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Change In Cash Supplemental As Reported | — | — | — | — | — | — | $276.2m | $144.1m | $104.0m | ($494.2m) | |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $148.3m | — | $211.9m | $205.9m | $216.2m | $214.4m | $220.7m | $234.5m | $231.0m | $224.0m | |
| Income Taxes Paid, Net | $4.9m | — | $4.8m | $5.1m | $7.0m | $6.3m | $5.8m | $3.6m | $8.4m | $4.3m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.